The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 26, 2024 | Viking Global Opportunities GP LLC | 10% Owner | Other(J) | 4.9M | — | — |
| Feb 26, 2024 | Viking Global Opportunities GP LLC | 10% Owner | Other(J) | 1.7M | — | — |
| Feb 26, 2024 | Ott David C. | 10% Owner | Other(J) | 1.7M | — | — |
| Feb 26, 2024 | Ott David C. | 10% Owner | Other(J) | 4.9M | — | — |
| Feb 26, 2024 | Song Kenneth | PRESIDENT AND CHIEF EXECUTIVE, Director | Disposed to issuer(D) | 1.6M | $62.50 | $101.4M |
| Feb 26, 2024 | Song Kenneth | PRESIDENT AND CHIEF EXECUTIVE, Director | Disposed to issuer(D) | 759K | — | — |
| Feb 26, 2024 | Song Kenneth | PRESIDENT AND CHIEF EXECUTIVE, Director | Disposed to issuer(D) | 480K | — | — |
| Feb 26, 2024 | Song Kenneth | PRESIDENT AND CHIEF EXECUTIVE, Director | Disposed to issuer(D) | 115K | — | — |
| Feb 26, 2024 | Kush Arvind | CHIEF FINANCIAL OFFICER | Disposed to issuer(D) | 78K | $62.50 | $4.9M |
| Feb 26, 2024 | Kush Arvind | CHIEF FINANCIAL OFFICER | Disposed to issuer(D) | 150K | — | — |
| Feb 26, 2024 | Kush Arvind | CHIEF FINANCIAL OFFICER | Disposed to issuer(D) | 164K | — | — |
| Feb 26, 2024 | Kush Arvind | CHIEF FINANCIAL OFFICER | Disposed to issuer(D) | 302K | — | — |
| Feb 26, 2024 | Moran Susan | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 323K | $62.50 | $20.2M |
| Feb 26, 2024 | Moran Susan | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 164K | — | — |
| Feb 26, 2024 | Moran Susan | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 78K | — | — |
| Feb 26, 2024 | Moran Susan | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 61K | — | — |
| Feb 26, 2024 | Moran Susan | CHIEF MEDICAL OFFICER | Disposed to issuer(D) | 195K | — | — |
| Feb 26, 2024 | Katabi Maha | Director | Disposed to issuer(D) | 1.2M | $62.50 | $75.6M |
| Feb 26, 2024 | Katabi Maha | Director | Disposed to issuer(D) | 1.2M | $62.50 | $75.6M |
| Feb 26, 2024 | Katabi Maha | Director | Disposed to issuer(D) | 18K | — | — |
| Feb 26, 2024 | Larson Yi | Director | Disposed to issuer(D) | 14K | — | — |
| Feb 26, 2024 | Larson Yi | Director | Disposed to issuer(D) | 59K | — | — |
| Feb 26, 2024 | Larson Yi | Director | Disposed to issuer(D) | 41K | — | — |
| Feb 26, 2024 | Heyman Richard A. | Director | Disposed to issuer(D) | 367K | $62.50 | $23.0M |
| Feb 26, 2024 | Tagliaferri Mary | Director | Disposed to issuer(D) | 74K | — | — |
| Feb 26, 2024 | Tagliaferri Mary | Director | Disposed to issuer(D) | 41K | — | — |
| Feb 26, 2024 | Van Hauwermeiren Timothy | Director | Disposed to issuer(D) | 49K | — | — |
| Feb 26, 2024 | You Angie | Director | Disposed to issuer(D) | 74K | — | — |
| Feb 26, 2024 | You Angie | Director | Disposed to issuer(D) | 41K | — | — |
| Feb 26, 2024 | Oliger Christy J. | Director | Disposed to issuer(D) | 115K | — | — |
| Jan 22, 2024 | Moran Susan | CHIEF MEDICAL OFFICER | Option exercise(M) | 31K | $3.24 | $100K |
| Jan 22, 2024 | Moran Susan | CHIEF MEDICAL OFFICER | Option exercise(M) | 31K | — | $0 |
| Nov 17, 2023 | Moran Susan | Chief Medical Officer | Grant(A) | 164K | — | $0 |
| Nov 17, 2023 | Katabi Maha | Director | Grant(A) | 18K | — | $0 |
| Nov 17, 2023 | Song Kenneth | President and Chief Executive, Director | Grant(A) | 480K | — | $0 |
| Nov 17, 2023 | Kush Arvind | Chief Financial Officer | Grant(A) | 164K | — | $0 |
| Nov 1, 2023 | Van Hauwermeiren Timothy | Director | Grant(A) | 49K | — | $0 |
| Sep 19, 2023 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 1.6M | — | — |
| Sep 19, 2023 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | Conversion(C) | 1.6M | — | $0 |
| Sep 19, 2023 | Adelman Robert J | 10% Owner | Conversion(C) | 216K | — | — |
| Sep 19, 2023 | Adelman Robert J | 10% Owner | Conversion(C) | 3.8M | — | — |
| Sep 19, 2023 | Adelman Robert J | 10% Owner | Conversion(C) | 1.1M | — | — |
| Sep 19, 2023 | Adelman Robert J | 10% Owner | Conversion(C) | 247K | — | — |
| Sep 19, 2023 | Adelman Robert J | 10% Owner | Conversion(C) | 3.8M | — | — |
| Sep 19, 2023 | Adelman Robert J | 10% Owner | Conversion(C) | 1.1M | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 865K | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 495K | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Buy(P) | 458K | $18.00 | $8.2M |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Buy(P) | 931K | $18.00 | $16.8M |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 1.3M | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 2.6M | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 1.3M | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 2.6M | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 432K | — | — |
| Sep 19, 2023 | Shabet Rose Sharon | 10% Owner | Conversion(C) | 865K | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 865K | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 2.6M | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Buy(P) | 931K | $18.00 | $16.8M |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Buy(P) | 458K | $18.00 | $8.2M |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 1.3M | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 495K | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 2.6M | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 1.3M | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 432K | — | — |
| Sep 19, 2023 | Viking Global Opportunities Drawdown GP LLC | 10% Owner | Conversion(C) | 865K | — | — |
| Sep 19, 2023 | Redmile Biopharma Investments II, L.P. | 10% Owner | Conversion(C) | 495K | — | — |
| Sep 19, 2023 | Redmile Biopharma Investments II, L.P. | 10% Owner | Conversion(C) | 499K | — | — |
| Sep 19, 2023 | Redmile Biopharma Investments II, L.P. | 10% Owner | Conversion(C) | 865K | — | — |
| Sep 19, 2023 | Redmile Biopharma Investments II, L.P. | 10% Owner | Conversion(C) | 432K | — | $0 |
| Sep 19, 2023 | Redmile Biopharma Investments II, L.P. | 10% Owner | Conversion(C) | 499K | — | $0 |
| Sep 19, 2023 | Redmile Biopharma Investments II, L.P. | 10% Owner | Conversion(C) | 865K | — | $0 |
| Sep 19, 2023 | Katabi Maha | Director | Conversion(C) | 974K | — | — |
| Sep 19, 2023 | Katabi Maha | Director | Buy(P) | 236K | $18.00 | $4.2M |
| Sep 19, 2023 | Katabi Maha | Director | Buy(P) | 236K | $18.00 | $4.2M |
| Sep 19, 2023 | Katabi Maha | Director | Conversion(C) | 974K | — | — |
| Sep 19, 2023 | Katabi Maha | Director | Conversion(C) | 974K | — | — |
| Sep 19, 2023 | Katabi Maha | Director | Conversion(C) | 974K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).